APO Research
Talk to an analyst

APO RESEARCH · REPORT

Apixaban

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Apixaban Market Outlook and Growth Opportunities 2026

21 December 2025191 pages

Choose your research edition.

Industry ResearchApixaban Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Apixaban Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Apixaban Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Apixaban Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Apixaban Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Apixaban market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Apixaban is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Apixaban is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Apixaban is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Apixaban market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Apixaban market include Pfizer, Polpharma, Medichem, Dipharma Francis, DEAFARMA, Centaur Pharmaceutical and Beijing Cooperate Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Apixaban market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Apixaban and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Apixaban sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Apixaban market size, projected growth trends, production technologies, key applications, and end-use industries.

Apixaban Segment by Company

Pfizer

Polpharma

Medichem

Dipharma Francis

DEAFARMA

Centaur Pharmaceutical

Beijing Cooperate Pharmaceutical

Apixaban Segment by Type

Capsule Apixaban

Tablet Apixaban

Apixaban Segment by Application

Hospital Pharmacy

Online Pharmacy

Retail Pharmacy

Apixaban Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Apixaban status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Apixaban market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Apixaban significant trends, drivers, influence factors in global and regions.

6. To analyze Apixaban competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Apixaban market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Apixaban and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Apixaban.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Apixaban market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Apixaban industry.

Chapter 3: Detailed analysis of Apixaban manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Apixaban in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Apixaban in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Apixaban Industry Trends Table 2. Apixaban Industry Drivers Table 3. Apixaban Industry Opportunities and Challenges Table 4. Apixaban Industry Restraints Table 5. Global Apixaban Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Apixaban Revenue Share by Company (2021-2026) Table 7. Global Apixaban Sales Volume by Company (k units) & (2021-2026) Table 8. Global Apixaban Sales Volume Share by Company (2021-2026) Table 9. Global Apixaban Average Price (US$/unit) of Company (2021-2026) Table 10. Global Apixaban Company Ranking, (2024-2026) & (USD Million) Table 11. Global Apixaban Key Company Manufacturing Base & Headquarters Table 12. Global Apixaban Company, Product Type & Application Table 13. Global Apixaban Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Apixaban by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Capsule Apixaban Table 18. Significant Companies of Tablet Apixaban Table 19. Global Apixaban Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Apixaban Sales Volume by Type (2021-2026) & (k units) Table 21. Global Apixaban Sales Volume by Type (2027-2032) & (k units) Table 22. Global Apixaban Sales Volume Share by Type (2021-2026) Table 23. Global Apixaban Sales Volume Share by Type (2027-2032) Table 24. Global Apixaban Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Apixaban Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Apixaban Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Apixaban Sales Value Share by Type (2021-2026) Table 28. Global Apixaban Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Pharmacy Table 30. Significant Companies of Online Pharmacy Table 31. Significant Companies of Retail Pharmacy Table 32. Global Apixaban Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Apixaban Sales Volume by Application (2021-2026) & (k units) Table 34. Global Apixaban Sales Volume by Application (2027-2032) & (k units) Table 35. Global Apixaban Sales Volume Share by Application (2021-2026) Table 36. Global Apixaban Sales Volume Share by Application (2027-2032) Table 37. Global Apixaban Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Apixaban Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Apixaban Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Apixaban Sales Value Share by Application (2021-2026) Table 41. Global Apixaban Sales Value Share by Application (2027-2032) Table 42. Global Apixaban Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Apixaban Sales by Region (2021-2026) & (k units) Table 44. Global Apixaban Sales Market Share by Region (2021-2026) Table 45. Global Apixaban Sales by Region (2027-2032) & (k units) Table 46. Global Apixaban Sales Market Share by Region (2027-2032) Table 47. Global Apixaban Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Apixaban Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Apixaban Sales Value Share by Region (2021-2026) Table 50. Global Apixaban Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Apixaban Sales Value Share by Region (2027-2032) Table 52. Global Apixaban Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Apixaban Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Apixaban Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Apixaban Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Apixaban Sales by Country (2021-2026) & (k units) Table 57. Global Apixaban Sales Market Share by Country (2021-2026) Table 58. Global Apixaban Sales by Country (2027-2032) & (k units) Table 59. Global Apixaban Sales Market Share by Country (2027-2032) Table 60. Global Apixaban Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Apixaban Sales Value Market Share by Country (2021-2026) Table 62. Global Apixaban Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Apixaban Sales Value Market Share by Country (2027-2032) Table 64. Pfizer Company Information Table 65. Pfizer Business Overview Table 66. Pfizer Apixaban Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Pfizer Apixaban Product Portfolio Table 68. Pfizer Recent Development Table 69. Polpharma Company Information Table 70. Polpharma Business Overview Table 71. Polpharma Apixaban Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Polpharma Apixaban Product Portfolio Table 73. Polpharma Recent Development Table 74. Medichem Company Information Table 75. Medichem Business Overview Table 76. Medichem Apixaban Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Medichem Apixaban Product Portfolio Table 78. Medichem Recent Development Table 79. Dipharma Francis Company Information Table 80. Dipharma Francis Business Overview Table 81. Dipharma Francis Apixaban Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Dipharma Francis Apixaban Product Portfolio Table 83. Dipharma Francis Recent Development Table 84. DEAFARMA Company Information Table 85. DEAFARMA Business Overview Table 86. DEAFARMA Apixaban Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. DEAFARMA Apixaban Product Portfolio Table 88. DEAFARMA Recent Development Table 89. Centaur Pharmaceutical Company Information Table 90. Centaur Pharmaceutical Business Overview Table 91. Centaur Pharmaceutical Apixaban Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Centaur Pharmaceutical Apixaban Product Portfolio Table 93. Centaur Pharmaceutical Recent Development Table 94. Beijing Cooperate Pharmaceutical Company Information Table 95. Beijing Cooperate Pharmaceutical Business Overview Table 96. Beijing Cooperate Pharmaceutical Apixaban Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Beijing Cooperate Pharmaceutical Apixaban Product Portfolio Table 98. Beijing Cooperate Pharmaceutical Recent Development Table 99. Key Raw Materials Table 100. Raw Materials Key Suppliers Table 101. Apixaban Distributors List Table 102. Apixaban Customers List Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. Apixaban Product Image Figure 2. Global Apixaban Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Apixaban Sales Value (2021-2032) & (US$ Million) Figure 4. Global Apixaban Sales (2021-2032) & (k units) Figure 5. Global Apixaban Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Apixaban Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Capsule Apixaban Image Figure 10. Tablet Apixaban Image Figure 11. Global Apixaban Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Apixaban Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Apixaban Sales Volume Share by Type (2021-2032) Figure 14. Global Apixaban Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Apixaban Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Apixaban Sales Value Share by Type (2021-2032) Figure 17. Hospital Pharmacy Image Figure 18. Online Pharmacy Image Figure 19. Retail Pharmacy Image Figure 20. Global Apixaban Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Apixaban Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Apixaban Sales Volume Share by Application (2021-2032) Figure 23. Global Apixaban Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Apixaban Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Apixaban Sales Value Share by Application (2021-2032) Figure 26. Global Apixaban Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Apixaban Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Apixaban Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Apixaban Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Apixaban Sales Value (2021-2032) & (US$ Million) Figure 31. North America Apixaban Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Apixaban Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Apixaban Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Apixaban Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Apixaban Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Apixaban Sales Value (2021-2032) & (US$ Million) Figure 37. South America Apixaban Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Apixaban Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Apixaban Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Apixaban Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Apixaban Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Apixaban Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Apixaban Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Apixaban Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Apixaban Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Apixaban Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Apixaban Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Apixaban Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Apixaban Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Apixaban Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Apixaban Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Apixaban Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Apixaban Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Apixaban Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Apixaban Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Apixaban Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Apixaban Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Apixaban Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Apixaban Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Apixaban Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Apixaban Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Apixaban Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Apixaban Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Apixaban Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Apixaban Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Apixaban Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Apixaban Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Apixaban Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Apixaban Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Apixaban Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Apixaban Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Apixaban Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Apixaban Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Apixaban Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Apixaban Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Apixaban Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Apixaban Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Apixaban Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Apixaban Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Apixaban Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Apixaban Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Apixaban Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Apixaban Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Apixaban Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Apixaban Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Apixaban Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Apixaban Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Apixaban Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Apixaban Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Apixaban Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Apixaban Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Apixaban Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Apixaban Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Apixaban Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Apixaban Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Apixaban Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Apixaban Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Apixaban Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Apixaban Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Apixaban Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Apixaban Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Apixaban Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Apixaban Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Apixaban Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Apixaban Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Apixaban Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Apixaban Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Apixaban Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Apixaban Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Apixaban Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Apixaban Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Apixaban Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Apixaban Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Apixaban Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Apixaban Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Apixaban Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Apixaban Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Apixaban Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Apixaban Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Apixaban Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Apixaban Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Apixaban Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Apixaban Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Apixaban Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Apixaban Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Capsule Apixaban
  • Tablet Apixaban
Applications
  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
Companies covered
  • Pfizer
  • Polpharma
  • Medichem
  • Dipharma Francis
  • DEAFARMA
  • Centaur Pharmaceutical
  • Beijing Cooperate Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Apixaban Sales Value (2021-2032)
  4. 1.2.2 Global Apixaban Sales Volume (2021-2032)
  5. 1.2.3 Global Apixaban Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Apixaban Market Dynamics
  1. 2.1 Apixaban Industry Trends
  2. 2.2 Apixaban Industry Drivers
  3. 2.3 Apixaban Industry Opportunities and Challenges
  4. 2.4 Apixaban Industry Restraints
3 Apixaban Market by Company
  1. 3.1 Global Apixaban Company Revenue Ranking in 2025
  2. 3.2 Global Apixaban Revenue by Company (2021-2026)
  3. 3.3 Global Apixaban Sales Volume by Company (2021-2026)
  4. 3.4 Global Apixaban Average Price by Company (2021-2026)
  5. 3.5 Global Apixaban Company Ranking (2024-2026)
  6. 3.6 Global Apixaban Company Manufacturing Base and Headquarters
  7. 3.7 Global Apixaban Company Product Type and Application
  8. 3.8 Global Apixaban Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Apixaban Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Apixaban Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Apixaban Market by Type
  1. 4.1 Apixaban Type Introduction
  2. 4.1.1 Capsule Apixaban
  3. 4.1.2 Tablet Apixaban
  4. 4.2 Global Apixaban Sales Volume by Type
  5. 4.2.1 Global Apixaban Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Apixaban Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Apixaban Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Apixaban Sales Value by Type
  9. 4.3.1 Global Apixaban Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Apixaban Sales Value by Type (2021-2032)
  11. 4.3.3 Global Apixaban Sales Value Share by Type (2021-2032)
5 Apixaban Market by Application
  1. 5.1 Apixaban Application Introduction
  2. 5.1.1 Hospital Pharmacy
  3. 5.1.2 Online Pharmacy
  4. 5.1.3 Retail Pharmacy
  5. 5.2 Global Apixaban Sales Volume by Application
  6. 5.2.1 Global Apixaban Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Apixaban Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Apixaban Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Apixaban Sales Value by Application
  10. 5.3.1 Global Apixaban Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Apixaban Sales Value by Application (2021-2032)
  12. 5.3.3 Global Apixaban Sales Value Share by Application (2021-2032)
6 Apixaban Regional Sales and Value Analysis
  1. 6.1 Global Apixaban Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Apixaban Sales by Region (2021-2032)
  3. 6.2.1 Global Apixaban Sales by Region: 2021-2026
  4. 6.2.2 Global Apixaban Sales by Region (2027-2032)
  5. 6.3 Global Apixaban Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Apixaban Sales Value by Region (2021-2032)
  7. 6.4.1 Global Apixaban Sales Value by Region: 2021-2026
  8. 6.4.2 Global Apixaban Sales Value by Region (2027-2032)
  9. 6.5 Global Apixaban Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Apixaban Sales Value (2021-2032)
  12. 6.6.2 North America Apixaban Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Apixaban Sales Value (2021-2032)
  15. 6.7.2 Europe Apixaban Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Apixaban Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Apixaban Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Apixaban Sales Value (2021-2032)
  21. 6.9.2 South America Apixaban Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Apixaban Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Apixaban Sales Value Share by Country, 2025 VS 2032
7 Apixaban Country-level Sales and Value Analysis
  1. 7.1 Global Apixaban Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Apixaban Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Apixaban Sales by Country (2021-2032)
  4. 7.3.1 Global Apixaban Sales by Country (2021-2026)
  5. 7.3.2 Global Apixaban Sales by Country (2027-2032)
  6. 7.4 Global Apixaban Sales Value by Country (2021-2032)
  7. 7.4.1 Global Apixaban Sales Value by Country (2021-2026)
  8. 7.4.2 Global Apixaban Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Apixaban Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Apixaban Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Apixaban Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Apixaban Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Apixaban Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Apixaban Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Apixaban Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Apixaban Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Apixaban Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Apixaban Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Apixaban Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Apixaban Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Apixaban Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Apixaban Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Apixaban Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Apixaban Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Apixaban Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Apixaban Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Apixaban Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Apixaban Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Apixaban Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Apixaban Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Apixaban Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Apixaban Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Apixaban Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Apixaban Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Apixaban Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Apixaban Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Apixaban Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Apixaban Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Apixaban Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Apixaban Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Apixaban Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Apixaban Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Apixaban Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Apixaban Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Apixaban Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Apixaban Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Apixaban Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Apixaban Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Apixaban Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Apixaban Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Apixaban Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Apixaban Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Apixaban Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Apixaban Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Apixaban Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Apixaban Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Apixaban Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Apixaban Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Apixaban Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Apixaban Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Apixaban Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Apixaban Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Apixaban Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Apixaban Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Apixaban Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Apixaban Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Apixaban Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Apixaban Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Apixaban Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Apixaban Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Apixaban Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Apixaban Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Apixaban Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Apixaban Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Apixaban Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Apixaban Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Apixaban Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Apixaban Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Apixaban Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Apixaban Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Apixaban Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Apixaban Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Apixaban Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Apixaban Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Apixaban Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Apixaban Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Apixaban Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Apixaban Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Apixaban Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Apixaban Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Apixaban Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Apixaban Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Pfizer
  2. 8.1.1 Pfizer Company Information
  3. 8.1.2 Pfizer Business Overview
  4. 8.1.3 Pfizer Apixaban Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Pfizer Apixaban Product Portfolio
  6. 8.1.5 Pfizer Recent Developments
  7. 8.2 Polpharma
  8. 8.2.1 Polpharma Company Information
  9. 8.2.2 Polpharma Business Overview
  10. 8.2.3 Polpharma Apixaban Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Polpharma Apixaban Product Portfolio
  12. 8.2.5 Polpharma Recent Developments
  13. 8.3 Medichem
  14. 8.3.1 Medichem Company Information
  15. 8.3.2 Medichem Business Overview
  16. 8.3.3 Medichem Apixaban Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Medichem Apixaban Product Portfolio
  18. 8.3.5 Medichem Recent Developments
  19. 8.4 Dipharma Francis
  20. 8.4.1 Dipharma Francis Company Information
  21. 8.4.2 Dipharma Francis Business Overview
  22. 8.4.3 Dipharma Francis Apixaban Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Dipharma Francis Apixaban Product Portfolio
  24. 8.4.5 Dipharma Francis Recent Developments
  25. 8.5 DEAFARMA
  26. 8.5.1 DEAFARMA Company Information
  27. 8.5.2 DEAFARMA Business Overview
  28. 8.5.3 DEAFARMA Apixaban Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 DEAFARMA Apixaban Product Portfolio
  30. 8.5.5 DEAFARMA Recent Developments
  31. 8.6 Centaur Pharmaceutical
  32. 8.6.1 Centaur Pharmaceutical Company Information
  33. 8.6.2 Centaur Pharmaceutical Business Overview
  34. 8.6.3 Centaur Pharmaceutical Apixaban Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Centaur Pharmaceutical Apixaban Product Portfolio
  36. 8.6.5 Centaur Pharmaceutical Recent Developments
  37. 8.7 Beijing Cooperate Pharmaceutical
  38. 8.7.1 Beijing Cooperate Pharmaceutical Company Information
  39. 8.7.2 Beijing Cooperate Pharmaceutical Business Overview
  40. 8.7.3 Beijing Cooperate Pharmaceutical Apixaban Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Beijing Cooperate Pharmaceutical Apixaban Product Portfolio
  42. 8.7.5 Beijing Cooperate Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Apixaban Value Chain Analysis
  2. 9.1.1 Apixaban Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Apixaban Sales Mode & Process
  6. 9.2 Apixaban Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Apixaban Distributors
  9. 9.2.3 Apixaban Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst